Slonomics®

Sloning BioTechnology is now part of the MorphoSys Group

MorphoSys AG - parent company of AbD Serotec - acquired Sloning BioTechnology’s proprietary advanced technology, Slonomics® in October 2010, which is a leading platform that we use to manufacture Slonomics® Mutant Gene libraries for protein engineering. Unlike traditional methods which rely on individually designed and synthesized single stranded oligos, which have to be joined (ligated) together, Slonomics® uses a library of pre-made double stranded triplets that act as universal building blocks sufficient for thousands of gene synthesis processes. The triplet library represents all possible sequence combinations necessary to build any desired DNA molecule.

Slonomics® Technology Platform

Slonomics® Mutant Gene Libraries

Slonomics® Gene Synthesis

Slonomics® in Industrial Biotechnology

Slonomics® by AbD Serotec

Slonomics® Therapeutic Applications